Speaker illustration

Doctor Darryl Leong

Population Health Research Institute, Hamilton (Canada)

Dr. Leong’s clinical interests include cardio-oncology, frailty, multi-morbidity and echocardiography. He is Director of the McMaster University and Hamilton Health Sciences Cardio-Oncology Program and Director of Internal Medicine Resident Research. Dr. Leong graduated from the University of Adelaide Medical School with Deans Listing and Honours for academic excellence in 2000. He completed his cardiology training, Doctor of Philosophy, Master of Public Health, and Master of Biostatistics degrees at the University of Adelaide, Australia. He has completed a post-doctorate fellowship in cardiovascular imaging at the Leiden University Medical Centre, the Netherlands, before re-locating to Canada. His research is supported by the Canadian Institutes of Health Research and the Canadian Cancer Society, and he has published >190 manuscripts including all the leading internal medical and cardiovascular journals. His h-index is 56 with >18,000 citations.

Global Congestive Heart Failure Frailty Study

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Registries on incident and prevalent heart failure

Thumbnail

Androgen deprivation therapy for prostate cancer, measures of adiposity and strength, and adverse cardiovascular outcomes: observations from 3000 men in 5 countries in the RADICAL PC study

Event: ESC Congress 2023

Topic: Cardio-Oncology

Session: Prediction and management of cardiovascular risk for patients with cancer

Thumbnail

GCHF - LVEF and RV size .

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Latest science in heart failure 2

Thumbnail

Cardiovascular Risk Factors and COVID19 Risk

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology

Session: Latest Science in COVID-19

Thumbnail

PURE Epidemiology Transition.

Event: ESC Congress 2019

Topic: Epidemiology

Session: Meet the trialist - PURE

Thumbnail

PURE - Contrasting patterns of cardiovascular disease, cancers and related mortality between high- versus low-middle income countries in 21 countries

Event: ESC Congress 2019

Topic: Epidemiology

Session: Hot Line Session 5

Thumbnail

New insights into anthropometrics and cardiovascular outcomes in 150 000 adults from 21 countries followed for 9 years: a PURE study

Event: ESC Congress 2019

Topic: Obesity

Session: Late Breaking Science in Prevention 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb